Antony Michalski

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study

Ed C. Schwalbe, Janet C. Lindsey, Sirintra Nakjang et al. · The Lancet Oncology · 2017 · 504 citations · Full text

Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease

Rebecca M. Hill, Sanne Kuijper, Janet C. Lindsey et al. · Cancer Cell · 2014 · 205 citations · Full text

P53-myc Interactions, Malignant Disease, Medicine +12

Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: Results of the first UKCCSG/SIOP CNS 9204 trial

Richard G. Grundy, Sophie Wilne, Kathryn J. Robinson et al. · European Journal of Cancer · 2009 · 145 citations

Neuro-oncology, Pediatric Brain Tumors, Radiation Therapy +11

Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study

Rebecca M. Hill, Stacey Richardson, Ed C. Schwalbe et al. · The Lancet Child & Adolescent Health · 2020 · 93 citations · Full text

Relapsed intracranial ependymoma in children in the UK: Patterns of relapse, survival and therapeutic outcome

B Messahel, S. Ashley, Frank Saran et al. · European Journal of Cancer · 2009 · 82 citations

Neuro-oncology, Pediatric Brain Tumors, Pediatric Neurosurgery +4